Home    Contact Us    Send to Colleague    Search 

5 Mar 2011
Dry Eye Syndrome

Compound with unique transdermal delivery in Phase I development for the treatment of Dry Eye Syndrome.  Company seeks development or licensing opportunity.  Data presented to the American College of Optometry. 

Return to Press Releases

© 2020 by Commercial Healthcare Partners. Website Design & Development by Birchwood Group   Commercial Healthcare Partners    Jim Usry